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Abstract
The interest in non-invasive brain stimulation techniques
is increasing in recent years. Among these techniques,
transcranial direct current stimulation (tDCS) has been
the subject of great interest among researchers because
of its easiness to use, low cost, benign profile of side
effects and encouraging results of research in the
field. This interest has generated several studies and
randomized clinical trials, particularly in psychiatry. In
this review, we provide a summary of the development
of the technique and its mechanism of action as well as
a review of the methodological aspects of randomized
clinical trials in psychiatry, including studies in affective
disorders, schizophrenia, obsessive compulsive disorder,
child psychiatry and substance use disorder. Finally,
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we provide an overview of tDCS use in cognitive
enhancement as well as a discussion regarding its
clinical use and regulatory and ethical issues. Although
many promising results regarding tDCS efficacy were
described, the total number of studies is still low,
highlighting the need of further studies aiming to
replicate these findings in larger samples as to provide a
definite picture regarding tDCS efficacy in psychiatry.

stimulation for the treatment of depressive or manic
[2]
symptoms . The interest on “brain polarization” (as
transcranial DC stimulation was described at that time)
nd
declined during the 2 half of the last century, with the
social stigma related to electroconvulsotherapy and
the “golden age” of psychopharmacology. Only in the
last 15 years, the findings that weak, DC stimulation
delivered transcranially (tDCS) could induce prolonged
[4,5]
neuroplastic changes in cortical excitability
with
[6]
functional effects in healthy subjects , contributed to
a resurgence of the interest in this technique not only
as research tool but also as a potential approach for
the treatment of several psychiatric disorders, such
major depressive disorder, schizophrenia, obsessivecompulsive disorder and also other psychiatric and
[7-11]
neurological disorders
.

Key words: Non-invasive brain stimulation; Transcranial
direct current stimulation; Psychiatry disorders; Review
© The Author(s) 2015. Published by Baishideng Publishing
Group Inc. All rights reserved.

Core tip: Transcranial direct current stimulation (tDCS)
has been the subject of great interest among researchers
because of its easiness to use, low cost, benign profile
of side effects and encouraging results of research in
the field. In this review, we provide a summary of the
development of the technique and its mechanism of
action as well as a review of the methodological aspects
of randomized clinical trials in psychiatry and we provide
an overview of tDCS use in cognitive enhancement
as well as a discussion regarding its clinical use and
regulatory and ethical issues.

Technical aspects and mechanisms of action of tDCS

tDCS is described as a non-invasive form of brain
stimulation that uses a low-intensity, constant current
[12]
applied directly to the head through scalp electrodes .
This form of brain stimulation can induce significant
currents in superficial cortical areas (see The stimulated
brain, Elsevier 2014, Chapter 2, for a review and further
references) and, since the current used is sub threshold,
it can modulate neuronal excitability without triggering
[13]
action potentials , by facilitation or inhibition of
spontaneous neural activity according to the polarity of
[14]
the electrodes . Generally, anodal stimulation induces
an increase of cortical excitability, whereas cathodal
stimulation decreases cortical excitability, effects that
[4,5]
may last beyond the stimulation period , up to 30-120
[15]
min . In fact, the polarity-dependent effects are more
complex and also dependent of the spatial organization
of the cells: inward current flow at the cortex (anodal
tDCS) generates hyperpolarization of apical dendritic
regions of pyramidal cortical neurons and depolarization
of somatic regions, whereas outward current flow
(cathodal tDCS) results in somatic hyperpolarization
and apical dendrite depolarization of pyramidal cortical
[16]
neurons .
The effects of tDCS are not only determined by the
[16]
polarity of the electrodes, but also with the dose .
This involves the current intensity (usually ranging
[12]
between 0.5 to 2 mA) , the duration of stimulation
[7]
(usually ranging between 5 to 40 min) and the size of
2[17]
the electrodes that varies from 3 to 100 cm . These
2
variables determine the current density (in A/m ) and
the total charge (in Coulombs) applied. Notwithstanding,
the actual current delivered to the cortex is also
influenced by several other uncontrollable factors such
[7]
as the impedance of the cephalic structures .
The electrode placement on the scalp is usually
determined using the international Electroencephalogram
[17]
(EEG) 10-20 System . Commonly, the active electrode
is placed on the scalp, whereas the reference electrode
can be placed on either another cephalic location
(bipolar or bicephalic montage) or an extracephalic

Tortella G, Casati R, Aparicio LM, Mantovani A, Senço N, D’
Urso G, Brunelin J, Guarienti F, Selingardi PML, Muszkat
D, Junior BSP, Valiengo L, Moffa AH, Simis M, Borrione L,
Brunoni AR. Transcranial direct current stimulation in psychiatric
disorders. World J Psychiatr 2015; 5(1): 88-102 Available from:
URL: http://www.wjgnet.com/2220-3206/full/v5/i1/88.htm DOI:
http://dx.doi.org/10.5498/wjp.v5.i1.88

INTRODUCTION
The interest in the brain stimulation using electricity
exists since the Roman Empire, when the physician
Scribonius Largus described the application of the electric
[1,2]
shocks from “torpedo fish” to relieve headache . In
recent history, the first report of cortical stimulation
occurred in 1802, when Giovanni Aldini described the
electrical stimulation of exposed human cortex. He also
reported the use of a voltaic pile to perform transcranial
[2,3]
electrical stimulation to treat melancholia . In fact,
the invention of the voltaic battery encouraged the
application of electrotherapy for medical purposes
th
th
and during the 19 and 20 centuries physicians
started to use galvanic batteries to perform electric
brain stimulation for the treatment of different mental
disorders with heterogeneous, dubious results.
Notably, these first interventions were largely empirical
and uncontrolled. Only in the 1950s and the 1960s
systematic research was conducted in animals models,
studying the effects of direct current (DC) on changing
cortical excitability, and in clinical trials, performing DC
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location (unipolar or monocephalic montage), usually
the shoulder or upper arm. The electric current enters
the brain through the anode, passes through the
scalp and skull before reaching cortical and subcortical
regions and finally leaves through the cathode (The
stimulated brain, Elsevier 2014, Chapter 2). The
current flow produced reaches deep structures and,
when using extracephalic electrodes, the midbrain
and spinal cord as well. Importantly, the conventional
montages used in tDCS present low precision - i.e.,
the current flow produced is not restricted to the area
under the electrodes but in fact spreads out to other
[18]
cortical regions between and around the electrodes .
The long-term effects of tDCS appear to operate
through bidirectional modifications of post-synaptic
connections similar to long-term potentiation (LTP) and
long-term depression (LTD), occurring through NMDA[19]
depended mechanisms . Indeed, repeated tDCS
sessions might further increase the duration of long[20]
term effects on behavioral outcomes .

effect, especially discomfort sensation. In a randomized
double blind crossover trial with 100 healthy volunteers,
[30]
O’Connell et al suggest that blinding in studies using
tDCS at intensities of 2 mA is inadequate once the
participants correctly judged the stimulation condition.
Furthermore, some authors suggest that longer
ramp-in phases are preferable for blinding purposes,
[24,31]
especially when daily tDCS sessions are applied
.
In fact, randomized clinical trials (RCTs) tDCS trials,
which use parallel designs, might provide a more
adequate blinding. In a recent RCT for major depression
with a factorial design and two active interventions
(sertraline/placebo and 2 mA active/sham tDCS),
blinding assessment of the pharmacological and nonpharmacological interventions was comparable, with
correctly blinding guessing primarily associated with
clinical improvement and adverse effects and not
[24]
blinding failure .
Skin redness and discomfort are common adverse
effects that can harm tDCS blinding, and some studies
have been performed in order to control them. Gua
[32]
rienti et al
found that topical pre-treatment with
ketoprofen 2% significantly attenuated the tDCSinduced erythema, with a medium effect as compared
to placebo. Moreover, the unblinding of this adverse
effect can be managed by avoiding the awareness
of participants (for instance, looking at the mirror or
contacting peers following stimulation) and raters (for
instance, by adopting a rest period between tDCS
[33]
session and the clinical interview). McFadden et al
reported the reduction of pain and discomfort associated
with tDCS by using local anesthetics. A recent report
showed that pretreatment with benzocaine 6%, a
topical numbing agent, can decrease the discomfort in
subjects during the stimulation using high definition (HD)
electrode design, which can enhance the efficiency of
[34]
the sham controlled studies .

Methodological aspects in clinical tDCS research

Over the past years, tDCS has been increasingly used
in clinical research, from basic neuroscience research
to a tool in the treatment of various neurologic and
[21,22]
psychiatric disorders
. In order to identify whether
the effects of tDCS are non-specific or random, the
use of a placebo (sham) group is mandatory in clinical
trials. Indeed, the use of placebo is a standard method
to blind participants and health care providers in
[23]
randomized, controlled trials . Within this context, the
development of reliable methods of sham stimulation
[24]
is challenging , as blinding failure can compromise
evaluations, resulting in biased assessment of intervention
effects.
The sham stimulation, method validated by Gandiga
[25]
and colleagues , is currently used in almost all tDCS
clinical trials. The procedure involves short-lasting
manual or automatic increase and decrease of current
delivered during the first moments (30-60 s) of the
stimulation session in order to simulate the same skin
[25-27]
sensations of the verum stimulation
. Palm and
[28]
colleagues
reported that using this blinding method
the subjects were not able to distinguish between
active and sham stimulation applied on prefrontal
areas. However, in this study, the investigators were
able to identify between active vs sham stimulation
group based on the skin redness provoked by the
active stimulation. In another research, Ambrus and
colleagues suggested that this method of blinding
is effective, not because the sham fade-out phase
mimics the presumed disappearance of the sensations
in the verum stimulation conditions, but because,
the cutaneous sensations associated with the sham
[29]
stimulation persist after the ramp-down phase .
Another concern of tDCS detection involves current
dose, which seems to be associated with active tDCS
[28]
detection
since it is related to immediate adverse
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Adverse effects and safety

The general impression is that tDCS is a safe technique
with mild and transient adverse effects (AEs). Human
data on safety and tolerability are largely provided
from single-session studies in healthy volunteers. In a
[31]
meta-analysis, Brunoni and colleagues
showed that
tDCS presents a benign profile of side effects when
used in 1-2 sessions for healthy volunteers; however,
they referred that only 56% of all reviewed studies
reported the presence/absence of AEs, concluding
that AEs are being insufficiently reported during tDCS
clinical research.
According to this meta-analysis, the most common
adverse effects are detected in the active group,
among which itching, tingling, headache, burning
sensation and discomfort (Table 1).
Although well investigated in adults, there is no
specific guidance for tDCS dosage in children. The
few studies investigating tDCS among the pediatric
population indicated that adverse effects were similar
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enhance them .
Compared to repetitive transcranial magnetic
stimulation (rTMS), tDCS is a relatively cheaper, easier
to use, more portable technique with even less adverse
effects. Such appealing characteristics motivated
the research of using tDCS for the treatment of
[11]
neuropsychiatric disorders (for a review see ), and,
among them, tDCS has been showing particularly posi
tive results in major depression.

Table 1 Adverse effects associated with transcranial direct
current stimulation
Adverse effects
Itching
Tingling
Headache
Burning
Discomfort

1

1

Active

Sham

46 (39.3%)
26 (22.2%)
17 (14.8%)
10 (8.7%)
12 (10.4%)

27 (32.9%)
15 (18.3%)
13 (16.2%)
8 (10%)
11 (13.4%)

1

Number of subjects reporting adverse symptom (% in the sample).
Adapted from Brunoni et al[31], 2011. A systematic review on reporting and
assessment of adverse effects associated with transcranial direct current
stimulation.

Major depressive disorder

Major depressive disorder is a severe psychiatric disorder,
chronic and prevalent, showing a life prevalence between
6% and 12% and yearly between 3% and 11% in the
[42]
whole world . Besides that, proximately 80% of the
patients present a recrudescence of depressive symptoms
after one year of treatment with antidepressant drugs
and up to 33% do not achieve complete remission after
the use of 2 or 3 medication trials, which characterizes
[43]
the treatment resistant depression . In view of its
complexity and heterogeneity, with variations in it
is etiology, symptoms, course and response to the
treatment, further investigation aiming to refine the
knowledge underlying neurobiology is needed, with
the goal to identify circuits and brain areas connected
with this pathology.
An important body of evidence coming from
neuroimaging studies suggests that depression is a
result of impairment in activity of neural circuits that
connects the dorsolateral prefrontal cortex (DLPFC) and
[44]
the limbic system to other subcortical structures . The
current neural models of depression propose that the
emotional deregulation is due to abnormalities in the
dorsal neural system (cognitive control system) and the
[45]
ventral neural system (emotional evaluation system) .
The dorsal system, which comprehends the DLPFC,
dorsomedial PFC, the anterior dorsal cingulate gyrus
and the hippocampus, is involved both in the cognitive
processing of emotional input as much as the voluntary
regulation of emotion. The ventral system, which
comprehends the amygdala, insula, the ventral striate,
dorsal cingulate gyrus and ventral PFC is critic for the
identification of the emotional meaning from both
internal or external stimuli, for the automatic generation
and regulation (regulation without any conscious effort)
of affective states, mediation of automatic response,
dependent of the stimuli and context that results in
the production of the affective states. It was proposed
that increase of ventral neural system activity and
decrease of the dorsal neural system activity can result
mainly in attention impairment, in the identification of
negative emotions and in other cognitive and vegetative
[46]
symptoms of the depressive disorder .

to adults, restricted to itching or tingling sensations
at the stimulation site and without the reporting of
[35]
any serious side effects . A naturalistic study in
14 children with language disorders showed that 10
sessions of tDCS were well tolerated and the main side
effect detected was irritability, followed by acute mood
[36]
changes, tingling and itching .
However, due to anatomical and neurophysiological
differences in the developing brain (i.e., skull thickness,
cerebrospinal fluid volume, white and gray matter
volumes) the dose parameters considered safe and
efficacious for the use in adults should be adjusted to
[37]
achieve comparable results in children .
[37]
Recently, Kessler et al conducted a study in order
to evaluate the safety aspects of tDCS in children.
Using magnetic resonance imaging (MRI), they derived
head individual models by two neurologically normal
children and by three adults with different head sizes
and circumferences; their analyses showed an overlap
of sensitivity between adults with smaller head size
and children aged between 8 and 12 years. Moreover,
they highlighted to pay of caution in applying current
intensities of 2 mA or greater in pediatric populations,
due to the fact that the average of the dose of current
over the cortical surface after the tDCS stimulation
after might be higher in children than adults.

USE OF TDCS IN PSYCHIATRIC
DISORDERS
As a neuromodulatory tool, tDCS was reappraised in
st
the turn of the 21 century, with the seminal works
[38]
[4]
of Priori , followed by Nitsche et al . They showed
that the induction of a weak, direct current through
electrodes placed over the scalp could increase (anode)
and decrease (cathode) cortical excitability beyond
the period of stimulation. It is exact mechanisms
of action are still being elucidated but it probably
operates by inducing small changes (< 1 mV) in the
[39]
membrane potential , thus acting in the frequency of
[40]
spike timing and modifying net cortical excitability .
The mechanisms of action of tDCS occur also at the
synaptic level. For instance, glutamate antagonists
abolish tDCS after-effects, while NMDA-agonists
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tDCS in the major depressive disorder

In depression, the rationale of the montage with the
anode positioned over the left DLPFC and the cathode
over the right DLPFC, the right supraorbital area or in
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an extra-cephalic position rests on: (1) the prefrontal
asymmetry theory of depression, with relative
hypoactivity over the left and relative hyperactivity
[47,48]
over the right
; (2) the improvement in working
memory and affective processing observed after one[49-51]
single tDCS session in depressed patients
; (3) the
top-down, neuromodulatory effects of tDCS, possibly
reversing the imbalance between hypoactive cortical
[48]
areas and hyperactive subcortical areas ; and (4)
the clinical effects observed in rTMS using either rapid,
facilitatory stimulation over the left DLPFC and slow,
[52,53]
inhibitory stimulation over the right DLPFC
.
In the beginning of this century, some RCTs investi
gating the efficacy of tDCS for treating depression
[54]
have showed promising results. Fregni et al (n = 10,
tDCS given at 1 mA, 20 min per session, 5 sessions on
[55]
alternate days) and Boggio et al
(n = 40, 2 mA, 20
min, 10 sessions on consecutive weekdays) both found
tDCS more effective than a sham control. Negative
results were found in the study conducted by Loo et
[56]
al
(n = 40, 1 mA, 20 min, 5 sessions on alternate
days followed by 5 further active treatments) clinically
meaningful improvement was seen with active tDCS
over 10 sessions of treatment, but differences failed to
reach statistical significance over the initial 5-session
sham-controlled comparison period.
Although a variety of studies have found promising
results in the reduction of depressive symptoms treated
with tDCS protocols, two recent meta-analyses found
[57]
different results. While Kalu et al
conducted a metaanalysis that found improvement in the depressive
symptoms in the active group compared with the sham
[58]
tDCS group, Berlim et al
did not find significant
differences in the rates of response between the active
and the sham treated groups, although it is important to
emphasize that those meta-analyses considered distinct
[57]
outcomes. Kalu et al considered the size of the effect
based on the depression classification scores while Berlim
[58]
et al focused on the rates of remission and response.
Some reasons for these mixed findings include relatively
small sample sizes, disparate treatment modalities
(including number of sessions, cathode positioning,
duration and intensity of the sessions, etc.) and different
depression characteristics (regarding refractoriness,
severity, mean age, unipolar vs bipolar depression and
concomitant use of pharmacotherapy) in the sample. In
[8]
fact, a more recent meta-analysis found that active vs
sham tDCS had greater efficacy considering depression
improvement as well as response and remission rates.
The largest controlled study so far about the
application of tDCS in depression was recently published
[59]
by Brunoni et al . The authors made a controlled
trial with 120 patients with depression. The results of
this factorial study in which patients were randomly
assigned to receive active tDCS/sham tDCS and verum
sertraline/placebo showed a significant improvement on
the depressive symptoms for the ones that took only
active tDCS or in combination with sertraline.
Nonetheless, further randomized clinical trials
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are necessary and, in fact, several trials evaluating
the clinical efficacy of tDCS in depression are being
currently performed worldwide. Therefore, in the next
years a definite answer regarding the role of tDCS in
the therapeutic arsenal of depression is expected.

Bipolar disorder

The etiopathogenic and physiopathological mechanisms
of bipolar depression are not yet completely known.
One important factor, however, seems to be the
“hereditary-genetic”. While the general risk to
develop the bipolar disorder in the general population
is between 1% and 2%, it goes up to 9% in first
degree relatives of a Bipolar “carrier”. The conformity
between homozygous twins varies between 40% and
50% and the heritability (proportion of disease risk
in the population due to genetic variation) can reach
[60]
80%-85% .
From the neuroimaging point of view, several studies
indicate the commitment of some structures involved
in the affective regulation, such as PFC, anterior
cingulate gyrus and amygdala. Neurophysiologic
studies in bipolar patients, in turn, indicate executive
and attention deficits, corroborating the idea of a
[61]
commitment of the PFC .

TDCS in bipolar depression

A recent study enrolling 31 patients (14 with bipolar
depression and 17 with unipolar depression) had all the
subjects submitted to a specific protocol: 5 sessions of
tDCS with 20 min each, using anodic stimulation over
the left DLPFC. The treatment was well tolerated by
all and no significant adverse effects were observed.
After the fifth tDCS session, depressive symptoms
decreased in both groups and the beneficial effects
[62]
lasted for a month .
[63]
Loo et al , in which eight patients with bipolar depr
ession (four in each group) were recruited, did not show
important results in RCT phase, however on follow up
approach the outcomes were more expressive. Thus,
new studies are needed to reinforce the rationale of use
in order to validate this technique in this illness.

Schizophrenia

Schizophrenia is a mental disorder that occurs in
[64]
0.5%-1.5% of the population . The clinical sympto
matology of the disorder can be divided in three groups
of symptoms: positive, negative and cognitive. The
positive symptoms are characterized by hallucinations,
delusions, thought disorders and movement disorders.
Negative symptoms involve blunted affect, lethargy,
and social withdrawal. Traditional antipsychotic
medications have limited efficacy in treating these
[65]
chronic, often refractory, symptoms . It is appraised
that patients treated with antipsychotics remit in 30%
of cases, respond partially in 30% and do not respond
[66]
in about 40% . The best pharmacological option is
clozapine, which is the first-line drug for patients with
treatment-resistant schizophrenia, defined as the failure
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of two adequate antipsychotic trials . About 30%
of patients treated with clozapine responds partially
[67]
and these cases are described as super-refractory .
These patients are treated of different ways. Even if
the evidence regarding non- pharmacological therapies
is still limited, a recent meta-analyses have shown
promising results in the application of rTMS in the
treatment of auditory verbal hallucinations and negative
[68,69]
symptoms
. Neuroimaging studies have highlighted
that these symptoms might be linked to abnormal brain
activities within large dysfunctional brain networks.
Auditory verbal hallucinations have been linked to
fronto-temporal abnormalities with an hyperactivity
[70]
in the left temporo-parietal junction
and negative
symptoms have been linked to hypoactivity in the right
[71]
and left prefrontal cortex .
Thanks to the excitatory effect of the anode and
the inhibitory effect of the cathode described in the
neurophysiological studies investigating the effect
of tDCS on motor cortex excitability, it has been
hypothesized that anodal tDCS applied over the left
prefrontal cortex (hypoactive) combined with cathodal
tDCS applied over the left temporo-parietal junction
(hyperactive) could alleviate auditory hallucinations
in patients with schizophrenia (for a review see
[72]
Mondino ). In the same way, bifrontal tDCS with
the anode placed over the left prefrontal region and
the cathode over its right homologue or the right
supraorbital region is assumed to decrease negative
symptoms. Based on these hypotheses, several
studies have investigated the clinical effects of tDCS
in these two indications in schizophrenia. Current
was set at an intensity of 2 mA and delivered during
20 min. The electrodes were placed over the scalp of
the subjects according to the 10/20 EEG international
system. The center of the electrode was placed on a
point situated midway between T3 and P3 to stimulate
the left temporo-parietal junction and on F3 (F4) or
between F3 and FP1 (F4 and FP2) to stimulate the left
(right) prefrontal region.
Another study evaluated 20 patients with predominant
negative symptoms and stable medication (> 3 wk) and
they were randomized to active or sham stimulation
[73]
groups . Anode was placed over the left DLPFC and
cathode over the right supraorbital area; tDCS was
delivered once a day for 10 d. The active group showed
significant amelioration in The Positive and Negative
Syndrome Scale two weeks after the end of stimulation.
Regarding bifrontal tDCS, only some case-studies
have highlighted the potential interest of tDCS to
[74,75]
reduce resistant negative symptoms
and catatonic
[76]
symptoms .
Regarding safety, on the total amount reported
in world literature of about 50 schizophrenic patients
that have received tDCS, the technique appears to be
[77]
remarkable safe in the short and medium-terms .
Regarding adverse effects, some reviews described
only mild adverse effects associated to tDCS such as
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tingling, itching and fatigue, similarly as observed in
[78,79]
literature
.
Of note, two recent case studies have reported the
clinical interest of original stimulation parameters using
transcranial random noise stimulation. This kind of
stimulation can be of interest to enhance clinical efficacy
[80,81]
of transcranial stimulation
. Finally, in the literature
there are only few studies that have investigated the
clinical efficacy of tDCS in schizophrenia. Promising
results have been reported but replication studies with
larger samples are needed before any conclusion.

Obsessive-compulsive disorder

Obsessive-compulsive disorder (OCD) has a 2%
[82,83]
lifetime prevalence in the general population
.
Commonly, OCD symptoms begin during childhood and
have a chronic course, causing severe impairments in
[84-86]
both interpersonal and occupational functioning
.
In addition, pharmacotherapy is only effective in
[87]
40%-60% of patients , and cognitive-behavior
therapy (CBT),which has been reported as the most
[88]
effective treatment for OCD , is not readily available to
the majority of patients. Overall, 30% of OCD patients
[89]
are refractory to any first or second line treatments .
Thus, the search for a clearer understanding of disease
etiology and the need for new approaches to treatmentresistant patients are paramount.
It has been proposed that OCD results from mal
functioning of cortico-striato-thalamo-cortical circuitry
including the medial prefrontal cortex (i.e., supple
mentary motor area-SMA and anterior cingulate cortexACC), the dorsolateral prefrontal cortex, orbitofrontal
[90]
cortex (OFC), and basal ganglia . This model informed
neurosurgical approaches to OCD, and resulted in
effective invasive treatments as evidenced by the FDA
humanitarian use approval for high frequency deep
[91]
brain stimulation (DBS) in treatment-resistant cases .
However, the need for noninvasive alternatives for
patients who do not respond to standard treatments
(e.g., serotonin reuptake inhibitors or CBT) remains.
While rTMS has shown promise when applied to the
[92]
SMA and to the OFC , tDCS has been less investigated
for the treatment of OCD. Therefore, questions about
which areas should be targeted and which parameters
should be used still need to be addressed. In one case
report, tDCS resulted ineffective when applied to the
[10]
DLPFC , whereas a 30% reduction in the Yale-Brown
Obsessive Compulsive Severity Scale was found in a
case of treatment-resistant OCD after cathodal tDCS to
[93]
[94]
the pre-SMA . Furthermore, D’Urso et al
reported,
in a randomized cross-over trial of anodal vs cathodal
tDCS to the pre-SMA, that the cathodal application
was significantly superior to anodal tDCS in reducing
OCD symptoms. The results of this study are in line
with findings of clinical efficacy of inhibitory rTMS to
[95]
pre-SMA , demonstrated to be hyperactive in OCD
patients during performance of cognitive tasks related
[96,97]
to attentional aspects of action control
.
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The evidence deriving from the clinical efficacy of
inhibitory rTMS and tDCS and from neurophysiological
measures of altered motor cortex excitability in
[91]
OCD , that normalized after 1-Hz rTMS to the pre[98]
SMA , suggests that the pre-motor/motor system
is abnormally hyperactive in OCD, and that there is a
pathophysiological link between such hyperexcitability
and OCD symptoms.
In this context, to optimize the effect of cathodal
tDCS in OCD, simulated predictions of electric flow
models would be an extremely useful strategy for
the design of future tDCS trials. By applying this
[99]
model, Senco et al
found that the application of
the active electrode (cathode) over the pre-SMA,
with the reference electrode (anode) positioned on an
extracephalic location (i.e., the subject’s right deltoid),
resulted in a distribution of the electrical field from
the medial prefrontal cortex to the striatum, therefore
reaching the cortical and subcortical brain areas which
are crucially involved in the pathophysiology of OCD.
Based on this model and on the promising results
about the efficacy of cathodal tDCS to pre-SMA in
treatment-resistant OCD, a randomized controlled trial
testing the clinical and neurobiological effects of tDCS
in OCD is underway.

observed, this protocol was well tolerated, without
[105]
reports of serious side effects Mattai . No study has
assessed so far the effect of tDCS for the treatment of
major depression in children and adolescents.
Attention deficit hyperactivity disorder is a behavioral
diagnosis of early childhood where children often have
changes in motor control development, and studies
with adults suggested that anodal tDCS in the DLPFC
may be associated with enhancement of cognitive
[106]
performance
. Currently, there are an increasing
number of studies investigating TMS as an evaluation
and therapeutic tool in ADHD, but no studies regarding
tDCS in children and adolescents with this diagnose.
During childhood and adolescence the developing
brain is probably more sensitive to interventions. This
might lead to better results comparing to adults, but
also to an increased risk of side effects, related to
[35]
possible negative or maladaptive plasticity . For this
reason, the application of tDCS in developmental age
should be considered only after convincing evidence
has been collected on adult populations, even when
dealing with disorders usually first diagnosed in infancy,
childhood, or adolescence. In the case of Autism,
despite two reports of positive findings about the use
of cathodal tDCS over the DLPFC for the treatment
of some autism-related core behavioral symptoms D’
[107]
Urso
no study has involved so far autistic patients
in the developmental age. Nonetheless, neuroplasticity
in important brain areas can hardly be controlled in
RCT even when using widely accepted and traditional
treatments as psychotropic medication, so that the
only available way to gather adequate data on efficacy
and side effects is testing directly the specific target
[2]
population . Indeed, a recently published review of
literature regarding non invasive brain stimulation in
childhood and adolescence highlighted the importance
of systematic research in dose-finding, with shamcontrolled, double-blinded studies that are capable to
provide important information not available from open
[35]
label studies .

TDCS in child psychiatry

The first onset of a variety of mental disorders
diagnosed in adults occurs in childhood or adolescence,
as for instance, impulse-control disorders, attention
deficit hyperactivity disorder (ADHD), phobias, separation
[100]
anxiety disorder and substance use disorder . Earlier
onset is associated with treatment delay, longer
duration of illness and poorer clinical and functional
outcomes, being an important cause of burden during
[101,102]
this period of life
. In this sense, the use of novel
treatments such as tDCS, should also be considered
for children and adolescents, and might constitute
a promising therapeutic and diagnostic tool, as the
capacity for brain plasticity is greater during this period
[103]
of life
. tDCS would be also an interesting tool to
explore which brain areas are particularly important
in each stage of development both in healthy and
[7]
pathological conditions . Nevertheless, the scope of
literature in child and adolescent psychiatry is still very
limited, with the majority of studies being case reports
and open label studies.
An open study evaluating autistic patients with
minimal verbal language have applied anodal tDCS
over the Broca’s area to improve language acquisition
and the results showed that mean vocabulary scores
were significantly higher after the intervention Schneider
[104]
et al
. One double-blind, sham-controlled trial
with 12 youths (age range from 10 to 17 years) with
schizophrenia evaluated the tolerability of tDCS. The
patients were assigned to anodal or cathodal stimulation
and both groups were stimulated for 20 min per day
during 10 d. Although no clinical improvement was
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Substance use disorders

The treatment of substance use disorders is usually
difficult and challenging. The central reward pathway,
critical in the mechanism of dependences, comprises
the dopaminergic system including the mesolimbic
cortical ventral tegmental area and projections to the
[108,109]
nucleus accumbens and the prefrontal cortex
.
Neuroimaging studies showed the important function
of the prefrontal cortex in substance use disorders,
being an important cortical structure in working memory
and executive functions, two cognitive domains that
[110]
are usually damaged in chemical dependencies
.
In literature, only few studies have investigated the
application of tDCS for the treatment of chemical
dependencies. Nonetheless, these studies have shown
a possible role of this technique for the treatment of
these conditions, especially by stimulating the activity

94

March 22, 2015|Volume 5|Issue 1|

Tortella G et al . Transcranial direct current stimulation in psychiatric disorders
of the prefrontal cortex. Thus, the efficacy of tDCS
in treating substance use disorders deserves further
investigation, as shown below.

adults. The main finding was a significant reduction in
the number of cigarettes smoked when participants
received active as compared to sham stimulation.

[111]

[118]

Cocaine: Goriniet et al
used tDCS over the DLPFC
in two samples of subjects (18 cocaine dependent
users and 18 control subjects) to investigate the
effects of increasing cortical excitability after right or
left anodal stimulation. The subjects were randomized
to receive left-anodal/right-cathodal stimulation, rightanodal/left-cathodal stimulation, or sham (placebo)
stimulation; each session was delivered at least 48 h
apart. The results showed that the activation of the
DLPFC (left and right) results in the reduction of risky
behaviors in both, patients and control subjects, in
cocaine dependent users. The authors concluded that
in the future tDCS could represent a valuable tool for
intervention in users of cocaine.

Food: Fregni et al
conducted a study on healthy
subjects who reported frequent food cravings. They
designed a sham controlled crossover study, applying
one session of tDCS stimulation (2 mA, 20 min) in
three different conditions: anodal-left/cathodal-right
DLPFC, cathodal-right/anodal-left DLPFC and placebo.
They observed a reduction of cue-induced food
craving when comparing active anodal left/cathodal
right DLPFC over the other groups and a lower caloric
ingestion when comparing active (both configurations)
to sham group.
[119]
Goldman et al
applied 1 session of tDCS (2 mA,
20 min, anodal prefrontal dorsolateral cortex right)
in healthy subjects that reporting food craving. The
study showed a reduction of craving in both sham and
active tDCS conditions. Moreover, the results indicated
decreased ratings for specific food items when
comparing active to sham tDCS.

Alcohol: A randomized sham-controlled study in which
13 subjects received three different types of bilateral
stimulation of DLPFC with tDCS: (1) active anodal left
and cathodal right tDCS; (2) active anodal right and
cathodal left tDCS; and (3) sham tDCS, have shown a
reduction of craving for alcohol in both active groups
[112]
compared to the sham group .
[113]
Moreover, Klausset et al
studied 35 subjects
randomized to receive active bilateral (left cathodal/
right anodal over the DLPFC) repetitive (five consecutive
2
days) tDCS (2 mA, 35 cm , two times daily stimulation
for 13 min with a 20-min interval) or sham-tDCS.
They observed that bilateral tDCS over DLPFC reduced
relapse probability in severe alcoholic subjects and
improved perception of quality of life.

[120]

Cannabis: Boggio et al
studied the effect of tDCS
on cannabis dependence. Twenty-five patients were
divided into three distinct groups: anode left/cathode
right, anode right/cathode left and sham stimulation.
The results showed a significantly decrease of the
craving for marijuana in the anodal right stimulation
group.

USE OF TDCS IN COGNITION
Results from several studies regarding the effects of
tDCS stimulation suggest that it could induce clinical
gains in major depressive disorder, schizophrenia
[121]
and substance use disorders
. In many studies,
researchers have noticed improvement in cognitive
aspects of patients, such as working memory,
[122]
attention, executive functions and processing speed .
Furthermore, reports have demonstrated its utility in
the facilitation of several cognitive domains, such as
[123,124]
implicit motor learning and visuo-motor learning
,
indicating its potential effectiveness on the modulation
of behavior through the modulation of neurotransmitterdependent plasticity on the network level.
The results of some studies in patients with major
depression suggest improvement in performance Digits
[125]
Test , increasing of correct responses in affective Go[51]
[49,63,126]
no-go , improving of attention and working memory
,
[127]
[126]
cognitive control
and processing speed . Some studies
in patients with Alzheimer’s disease showed improvement
[127]
in recognition memory
and visual recognition memory
[128,129]
Boggio et al
after stimulation with tDCS. One
study reported an improvement in learning probabilistic
membership functions in schizophrenic patients after
[130]
tDCS
. Another study in 18 schizophrenic patients
[131]
showed an improvement in working memory . Finally,
a study of alcoholic subjects showed that after five

[114]

Nicotine: Fregni et al
have investigated 24 patients,
who received three different condition of a single tDCS
session in a randomized order: sham stimulation,
anode on the right DLPFC and anode the left DLPFC.
The authors observed a reduction of craving in both
active groups compared to the sham group.
Another study evaluated the effects of five consecutive
sessions of tDCS on DLPFC. Twenty seven patients
were randomized into two distinct groups: left anode
and sham stimulation. The results showed a small
but significant reduction in cigarette consumption and
[115]
craving in active vs sham groups .
A more recent study showed that anodal stimulation
over the left DLPFC improved smoking-related negative
affect, but did not improve the fissure. The authors
studied 24 smokers who received one real session and
one sham session of tDCS after overnight abstinence
from smoking in two different days. They applied anodal
tDCS to the left dorsolateral prefrontal cortex and
cathode to the right supra-orbital area for 20 min with a
[116]
current intensity of 2.0 mA .
[117]
Fecteau et al
rated two five-day tDCS regimens
(active or sham). Stimulation was delivered over
the right DLPFC at a 2 mA during 30 min in twelve
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weeks of stimulation, the subjects showed significant
[132]
improvement in executive functions .
With the same logic that the effects of tDCS showed
cognitive improvement in psychiatric and neurological
patients, studies with healthy subjects have shown that
tDCS can promote changes in cognitive function after
[6]
only one session or even after a series of sessions .
Several studies have demonstrated the effects of tDCS
[133]
on different cognitive functions in healthy subjects .
In order to study further the relationship between
tDCS and cognition, some researchers have decided
to study neural underpinning effects on cognition.
Supported by the observation that anodal tDCS over
the left DLPFC could improve naming performance
[134]
in healthy participants
investigated the putative
neurophysiological mechanisms underpinning language
production. The authors found the reduction of
semantic interference after anodal stimulation. Other
studies have been conducted to explore the inhibitory
[133]
effect of the technique .
This area of study may contribute in the future in the
investigation of the application of tDCS as an important
non-invasive tool for the rehabilitation of cognitive
functions. However, the studies so far available suggest
that the changes in cognitive performance observed
after tDCS stimulation are short-lived; this warrants
more studies to better explore the development of
the application of tDCS in patients with neurocognitive
disorders.

clinical evidence of effectiveness. To our knowledge,
there is no country that regulated the use of tDCS in
clinical practice as an on-label treatment, although
the evidence of the benefit of tDCS is increasing. For
instance, a recent meta-analysis found that active
tDCS was statistically superior to sham for treatment
[8]
of acute depression . The regulation in several
countries tends to be very restrictive, since it is also
used to determinate medical insurance coverage and
public health politics. Moreover, in our opinion, tDCS
device should be regulated as a medical device, since
it fulfills the criteria for this, at least for the United
[136]
States Foods and Drugs Administration .
Frequently, the regulation for clinical use also
defines the professional category that could perform
the therapy. We advocate that tDCS should have
similar regulation of the psychotropic medications,
since it has direct effect in the brain. In our opinion,
the stimulation could be applied by trained technicians,
but always with medical indication and supervision,
although this is not necessarily a consensus in scientific
community.
Although it is still necessary a better understanding
of the parameters of stimulation and the long terms
effect of tDCS for therapy, it is being already used
in some countries as off-label and compassioned
treatment. The use in this situation is normally justified
by the lack of conventional treatment for neurologic
and psychiatric diseases.

REGULATORY ISSUES

ETHICAL ISSUES

There are over 1200 tDCS publications in Pubmed,
with more than 200 being clinical trials for multiple
clinical disorders. The potential of tDCS for clinical
practice has been demonstrated for psychiatric and
cognitive disorders, as described above, for psychiatric
conditions associated with neurologic disorders, such
as depression in Parkinson diseases and stroke, but
also for tinnitus, chronic pain and motor deficit due to
different neurological diseases.
An interesting aspect of tDCS is that it has a low
risk; it is simple to operate, being portable and having
a relatively low cost. On the other hand these same
characteristics increases the chance of misuse, such as
enhancement application, recreational using and using
without supervision (as discussed below in ethical
issues), which increases the need for regulations
concerning the use of tDCS.
A worldwide implementation of tDCS regulation is
not straightforward, since each country follows its own
medical, sanitary and legislatory rules. Commonly, the
use of tDCS devices in research requires an approval
by the local ethics committee, which, in several
countries follows, at least partially, the World Medical
[135]
Association-Declaration of Helsinki .
For clinical purposes, it is necessary the regulation
of a new treatment according to the country’s internal
policies, which is based on ethical aspects, safety and

As all medical interventions in clinical practice and
research, tDCS raises general and specific ethical
issues that must be promptly addressed. Wider
ethical issues regarding tDCS encompass the pillars of
bioethics, namely, the principles of non-maleficence,
[137]
beneficence, autonomy and justice
. Nonetheless,
the definition and overall discussion of these paradigms
surpass the scope of this section of the paper.
The specific ethical issues raised by the growing
use of neuromodulation techniques, of which tDCS is a
part, are plentiful. Topics particularly relevant are: the
“cosmetic use” of tDCS as a cognitive-enhancement
procedure (i.e., for non-research or non-therapeutic
objectives), the hypothetical long-term effects of tDCS
on other mental faculties of its recipients, and the
inappropriate assemblage and use of tDCS devices by
[7,138,139]
nonmedical population, in nonclinical settings
.
There are several medical interventions (both
pharmacological and non-pharmacological) aimed at
improving cognitive faculties in some neuropsychiatric
disorders. For instance, methylphenidate is medically
approved to treat ADHD, and thereby improve the
patient’s ability to concentrate and appropriately conclude
tasks. On the other hand, this drug is knowingly misused
by healthy populations, who end up taking it to
improve their performance in situations like academic
presentations and exams. The same phenomenon
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[143]

could occur with tDCS. Consequentially, an intervention
initially devised to treat pathological conditions, such
as major depressive disorder, and lead to recovery of
secondary cognitive deficits, might mistakenly be used
[138]
for cosmetic cognitive enhancement .
The major concern about the indiscriminate use of
tDCS, especially for cosmetic purposes, is that since
it is a relatively novel method, and in many ways still
in phases of research, its long-term side effects are
not completely known. Despite its notorious shortterm safety with minimal and benign side effects,
there is preliminary evidence pointing to possible and
unforeseen interference of tDCS with the individual’s
[139]
[140]
social cognition
, moral judgment
and even the
[141]
capacity to tell the truth or deceive others
. While
such effects might be of minimal clinical relevance
when tDCS is applied correctly in clinical settings, with
adequate monitoring of individual responses, the same
cannot be said about its cosmetic use.
Finally, it is important to recognize that while the
equipment necessary to perform other neuromodulatory
techniques is expensive and not portable (rTMS, for
instance), naturally limiting their use in nonclinical
settings, the device used in tDCS is lightweight, portable
[138]
and can be assembled inexpensively
. Moreover, it
can be used at home, and in fact, there are websites
and open discussion groups aimed at instructing
nonmedical population on how to independently apply
tDCS on oneself.
Therefore, as the practice of tDCS becomes wide
spread, physicians and researchers need to be very
attentive to its correct clinical use, its long-term effects
on cognition, moral judgment and personality, and
cooperate with governmental regulation regarding
the manufacture and commercialization of its devices
and apparel. Needless to mention, all to safeguard the
appropriate autonomy of our patients, while helping
them make the best decisions with regard to their
mental and physical health.

as neurology . Along with promising results, comes
the excitement and interest of the media. The ethical
aspects surrounding the tDCS is being intensively
discussed. This is necessary to maintain scientific
rigor in terms of the information that reaches the lay
[142]
public .
With the promising results found in different psychiatric
disorders, further studies, with robust methodologies,
should strive to replicate, expand and optimize the
findings, perhaps testing larger, different samples
and also varying tDCS parameters such as electrode
size, dosage, reference electrode, length of sessions,
number of days of application are still warranted in
order to provide a definite picture regarding tDCS
clinical efficacy in psychiatry.
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